Just 18% of people who have had kidney transplants develop antibody responses to COVID-19 vaccines
A new study from Rouen Hospital in France found that after two doses of Pfizer's vaccine, 88.9% of dialysis patients developed antibodies against the virus compared to 17.8% of transplant recipients.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
More News: COVID-19 | Dialysis | France Health | Health | Hospitals | Kidney Transplant | Kidney Transplantation | Pfizer | Study | Transplant Surgery | Transplants | Urology & Nephrology | Vaccines